Lu Hong-zhou, Zhang Yue-xin, Zhou Zeng-quan, Ye Han-hui, Zhao Qing-xia, Wang Hui, Wang Fu-xiang, Jia Wang-qian, Sun Hong-qing, Jiang Xue-yan, Ding Li-min, Su Yan, He Yun, Maimaitiaili Wubuer, Yibaguli Aibaidoula, Sun Xiao-feng, Liu Bao-rong, Hu Ya-dong, Tang Wei, Zhou Bo-ping, Cao Yun-zhen
Shanghai Public Health Center, Fudan University, Shanghai 201508, China.
Zhonghua Nei Ke Za Zhi. 2007 Apr;46(4):280-3.
In order to take an insight into the profile of HIV/AIDS and tuberculosis (TB) co-infection, we made a statistic survey in 9 hospitals in mainland China. With the purpose of guiding the prevention and treatment, 241 cases with such co-infection were enrolled and the data with respect to clinical manifestations, laboratory tests, therapy and prognosis were analysed.
All indices were collected with unified questionary.
Young men (75.9%) took constituted the majority. HIV was transmitted mainly by intravenous drug use (IDU) in Xinjiang and Yunnan provinces, by blood transfusion or blood products in Shanghai, Henan and Wenxi county of Shanxi, and by sexual transmission in Fuzhou, Shanghai, Shenzhen and Dehong prefecture of Yunnan province. In this survey, pulmonary TB accounted for 59.3%, extra-pulmonary TB for 21.2%, and both for 19.5% of the patients. As for laboratory tests, only 9.5% was positive in sputum for acid-fast bacillus (AFB) and 2.9% in culture, 10.8% of the patients had AFB in pleural fluid or cerebrospinal fluid. Besides, PPD was negative or weakly positive in most of the cases. Overall, 76.8% of the 241 cases had a CD(4) cell count < 200/microl, and 58.5% < 100/microl. 80.5% of the patients was treated with anti-tuberculous medications and 69.7% with highly active antiretroviral therapy (HAART). 203 (84.2%) were still alive and 38 (15.8%) died.
(1) The clinical manifestations of the 241 cases were varied because of prevailing pulmonary TB. (2) The immune function was depressed with reducing CD(4) counts in most of the patients. (3) Positivity rate of examination relevant to TB was too low to help the diagnosis. (4) The mortality (15.8%) was high even with HAART and/or chemotherapy.
为深入了解艾滋病病毒/艾滋病(HIV/AIDS)合并结核病(TB)感染情况,我们对中国大陆9家医院进行了统计调查。为指导防治工作,纳入241例合并感染患者,并对其临床表现、实验室检查、治疗及预后数据进行分析。
所有指标均通过统一问卷收集。
年轻男性占多数(75.9%)。在新疆和云南省,HIV主要通过静脉吸毒(IDU)传播;在上海、河南和山西闻喜县,主要通过输血或血液制品传播;在福州、上海、深圳和云南省德宏州,主要通过性传播。本次调查中,肺结核患者占59.3%,肺外结核患者占21.2%,两者均有的患者占19.5%。实验室检查方面,痰涂片抗酸杆菌(AFB)阳性率仅为9.5%,培养阳性率为2.9%,10.8%的患者在胸水或脑脊液中发现AFB。此外,多数病例结核菌素试验(PPD)为阴性或弱阳性。总体而言,241例患者中76.8%的CD4细胞计数<200/μl,58.5%<100/μl。80.5%的患者接受了抗结核药物治疗,69.7%的患者接受了高效抗逆转录病毒治疗(HAART)。203例(84.2%)患者仍存活,38例(15.8%)死亡。
(1)241例患者临床表现多样,肺结核较为常见。(2)多数患者免疫功能因CD4细胞计数降低而受损。(3)结核病相关检查阳性率过低,不利于诊断。(4)即使采用HAART和/或化疗,死亡率(15.8%)仍较高。